GLIPR1 and neoplasm: A reduction in tumour burden was observed in mice inoculated with 5TGM1-Glipr1 cells compared to mice inoculated with 5TGM1-EV cells after four weeks, but this difference did not reach statistical significance in the 5TGM1/KaLwRij model.